TLPH Q1 2024 Earnings — Talphera, Inc. Revenue & Financial Results | Market Cap Arena

TLPHTalphera, Inc.

$18M

Q1 2024 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$0

Gross Profit

-$1M

Operating Income

-$4M

Net Income

-$4M

EPS (Diluted)

$-0.16

QoQ Revenue Growth

-100.0%

Cash Flow

Operating Cash Flow

-$3M

Free Cash Flow

-$3M

Stock-Based Comp.

$302,000

Balance Sheet

Total Assets

$29M

Total Liabilities

$12M

Stockholders' Equity

$16M

Cash & Equivalents

$12M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$1M	-$1M	-36.9%
Operating Income	-$4M	-$5M	+20.5%
Net Income	-$4M	-$8M	+51.5%